Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This describes the 'Explore Data' table.

...

portal namesynapse file view columneventual synapse file view columnfacetcard locationconceptexampleGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portal
Grant TypegrantTypeyesNA
U54 or U01








GrantcenterNameyes










NAProgramProgramconsortiumyesNA
CSBC or PSON








Speciesspeciesspeciesyessecondary

none
yes





Scientific ThemeNAthemeThemeyessecondary(or possibly pill directly beneath file name)
tumor-heterogeneitynone
yes





Data CategoryassayNAdata_categoryyessecondarynoBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data TypeNAdata_typeno?NASpecific content type of the data file.
  • Exon Expression Quantification
  • Gene Expression Quantification
  • Isoform Expression Quantification
  • Splice Junction Quantification
data_typeyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data FormatfileFormatdata_formatno?NAyesFormat of the data files.
  • CSV
  • HDF5
  • TSV
  • TXT
  • SRA XML
  • MAGE-TAB
  • SDRF
  • IDF
  • ADF
data_formatyesyes





Experiment StrategyAssayassayexperimentalStrategyexperimental_strategyyessecondaryThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

File NamenamenoprimaryThe name (or part of a name) of a file (of any type).
file_namenono





file_sizeNAnoNAThe size of the data file (object) in bytes.
file_sizenono





md5sumNAnoNAThe 128-bit hash value expressed as a 32 digit hexadecimal number (in lower case) used as a file's digital fingerprint.
md5sumnono





PlatformplatformyesNA

platformyesyes





Disease TypetumorTypeyessecondaryThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




SiteyesNAsecondarynoThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




EthnicityNAnoNAAn individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • hispanic or latino
  • not hispanic or latino
  • Unknown
  • not reported
  • not allowed to collect
demographic/ethnicityyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




GendernosexNAyesText designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]
  • female
  • male
  • unknown
  • unspecified
  • not reported
demographic/genderyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




RaceNAnoNAAn arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • white
  • american indian or alaska native
  • black or african american
  • asian
  • native hawaiian or other pacific
demographic/raceyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




TissuetissueyessecondaryThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Ageyes (can we facet by range–i.e., between age 20 and 30?)NAAge at the time of diagnosis expressed in number of days since birth.NAno

diagnosis/age_at_diagnosisyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Primary DiagnosisNAnoNAText term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdominal desmoid
  • Abdominal fibromatosis
  • Achromic nevus
  • Acidophil adenocarcinoma
  • Acidophil adenoma
diagnosis/primary_diagnosisnonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




ProgressionNAnoNAYes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
  • yes
  • no
  • unknown
  • not reported
  • Not Allowed To Collect
diagnosis/progression_or_recurrencenonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Vital StatusNAnoNAThe survival state of the person registered on the protocol.
  • alive
  • dead
  • lost to follow-up
  • unknown
  • not reported
diagnosis/vital_statusyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Sample TypeNAnoNAText term to describe the source of a biospecimen used for a laboratory test.
  • Additional Metastatic
  • Additional - New Primary
  • Blood Derived Cancer - Bone Marrow, Post-treatment
  • Blood Derived Cancer - Peripheral Blood, Post-treatment
  • Blood Derived Normal
  • Bone Marrow Normal
  • Buccal Cell Normal
  • Cell Line Derived Xenograft Tissue
  • Cell Lines
sample/sample_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




Tissue TypeNAnoNAText term that represents a description of the kind of tissue collected with respect to disease status or proximity to tumor tissue.
  • Tumor
  • Normal
  • Abnormal
  • Peritumoral
  • Unknown
sample/tissue_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




...